MNPR Return on Tangible Equity | Monopar Therapeutics Inc.

Monopar Therapeutics Inc. (MNPR) Return on Tangible Equity

2026-06-30: Return Tang Equity -13.64%.
2026-03-31: Return Tang Equity -11.07%.
2025-12-31: Return Tang Equity -9.95%.
2025-09-30: Return Tang Equity -13.73%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-13.64%
2026-03-31	-11.07%
2025-12-31	-9.95%
2025-09-30	-13.73%
2025-06-30	-33.16%
2025-03-31	-30.92%
2024-12-31	-28.32%
2024-09-30	-130.89%
2024-06-30	-116.98%
2024-03-31	-101.76%
2023-12-31	-150.37%
2023-09-30	-143.46%
2023-06-30	-126.72%
2023-03-31	-117.32%
2022-12-31	-104.22%
2022-09-30	-82.33%
2022-06-30	-71.36%
2022-03-31	-57.03%
2021-12-31	-48.06%
2021-09-30	-40.19%
2021-06-30	-33.11%
2021-03-31	-28.28%
2020-12-31	-40.18%
2020-09-30	-30.77%
2020-06-30	-36.86%
2020-03-31	-31.78%
2019-12-31	-33.46%
2019-09-30	-84.51%
2019-06-30	-74.37%
2019-03-31	-61.43%
2018-12-31	-44.04%
2018-09-30	-37.89%
2018-06-30	-210.58%
2018-03-31	-192.58%
2017-12-31	-172.10%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-9.95%
2024-12-31	-28.32%
2023-12-31	-150.37%
2022-12-31	-104.22%
2021-12-31	-48.06%
2020-12-31	-40.18%
2019-12-31	-33.46%
2018-12-31	-46.66%
2017-12-31	-172.10%
2016-12-31	-41.88%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
CorMedix Inc. (CRMD)	United States	$0.605B	3.25
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
Neurogene Inc. (NGNE)		$0.625B	-4.46
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B